← All candidates
3 insider filings on record.
3 filings on record.
ALLRAllarity Therapeutics, Inc.
—
$1.15
+4.05% · Sep 16
3 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 4×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what ALLR ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Short % float
Pro
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$10.25 avg target
+787.4% vs today · 1 analyst
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q2 '26−$0.21 act+$0.04
Q1 '26−$0.17 act+$0.05
Q4 '25−$0.21 act+$0.01
Q3 '25−$0.19 act+$0.04
Coverage
Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year?Zacks · 07-22Is Allarity Therapeutics, Inc. (ALLR) Stock Outpacing Its Medical Peers This Year?Zacks · 07-06Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year?Zacks · 06-19Allarity closes $20M financing for stenoparib advancementTipRanks · 03-07
The file stays open
3 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice